Jounce Therapeutics Stock Price, News & Analysis

JNCE NASDAQ

Company Description

Jounce Therapeutics (NASDAQ: JNCE) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

JNCE stock has declined 63.2% over the past year.

This page provides a comprehensive overview of JNCE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-63.21%

Performance 1 year

$0.0

Market Cap

52.6M

Shares outstanding

Jounce Therapeutics (JNCE) stock. Over the past 12 months, the stock has lost 63.2%.

Latest News

View All

May 4, 2023

0.00%

Jounce Therapeutics Announces Closing of Tender Offer

April 3, 2023

0.00%

Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc

March 27, 2023

+21.19%

Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights

acquisition

March 16, 2023

+3.21%

Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer

clinical trial

March 15, 2023

+40.57%

Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

February 23, 2023

+11.07%

Redx and Jounce Announce Recommended Business Combination

Jounce Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, clinical trial. View all JNCE news →

SEC Filings

View All

No SEC filings available for JNCE.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

JNCE Company Profile & Sector Positioning

Jounce Therapeutics (JNCE) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.